NCT02231723 A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02192359 Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02172976 Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT02171325 Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment Status UNKNOWN Phase PHASE2
NCT02143219 Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02138617 Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02129257 Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02119026 Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02096354 A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02087475 Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin Status UNKNOWN Phase PHASE3
NCT02071069 Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT02046538 Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT02044120 ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma Status COMPLETED Phase PHASE1
NCT02035137 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat Status COMPLETED Phase PHASE2
NCT02030678 A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT02024607 A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02021422 A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy Status COMPLETED Phase PHASE1
NCT01999270 Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors Status COMPLETED Phase PHASE1
NCT01977235 Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer Status UNKNOWN Phase PHASE2